Brachytherapy source characterization for improved dose calculations using primary and scatter dose separation.

In brachytherapy, tissue heterogeneities, source shielding, and finite patient/phantom extensions affect both the primary and scatter dose distributions. The primary dose is, due to the short range of secondary electrons, dependent only on the distribution of material located on the ray line between the source and dose deposition site. The scatter dose depends on both the direct irradiation pattern and the distribution of material in a large volume surrounding the point of interest, i.e., a much larger volume must be included in calculations to integrate many small dose contributions. It is therefore of interest to consider different methods for the primary and the scatter dose calculation to improve calculation accuracy with limited computer resources. The algorithms in present clinical use ignore these effects causing systematic dose errors in brachytherapy treatment planning. In this work we review a primary and scatter dose separation formalism (PSS) for brachytherapy source characterization to support separate calculation of the primary and scatter dose contributions. We show how the resulting source characterization data can be used to drive more accurate dose calculations using collapsed cone superposition for scatter dose calculations. Two types of source characterization data paths are used: a direct Monte Carlo simulation in water phantoms with subsequent parameterization of the results, and an alternative data path built on processing of AAPM TG43 formatted data to provide similar parameter sets. The latter path is motivated of the large amounts of data already existing in the TG43 format. We demonstrate the PSS methods using both data paths for a clinical Ir192 source. Results are shown for two geometries: a finite but homogeneous water phantom, and a half-slab consisting of water and air. The dose distributions are compared to results from full Monte Carlo simulations and we show significant improvement in scatter dose calculations when the collapsed-cone kernel-superposition algorithm is used compared to traditional table based calculations. The PSS source characterization method uses exponential fit functions derived from one-dimensional transport theory to describe both the primary and scatter dose contributions. We present data for the PSS characterization method to different Ir192, Cs137, and Cs60 brachytherapy sources. We also show how TG43 formatted data can be derived from our data to serve traditional treatment planning systems, as to enable for a gradual transfer to algorithms that provides improved modeling of heterogeneities in brachytherapy treatment planning.

[1]  S. C. Prasad,et al.  Buildup factors and dose around a 137Cs source in the presence of inhomogeneities. , 1983, Medical physics.

[2]  H. Meertens,et al.  Screens in ovoids of a Selectron cervix applicator. , 1985, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[3]  A. Ahnesjö Collapsed cone convolution of radiant energy for photon dose calculation in heterogeneous media. , 1989, Medical physics.

[4]  K. Weeks,et al.  Dose calculation and measurements for a CT compatible version of the Fletcher applicator. , 1990, International journal of radiation oncology, biology, physics.

[5]  S. Chiu‐Tsao,et al.  Thermoluminescent dosimetry for 103Pd seeds (model 200) in solid water phantom. , 1991, Medical physics.

[6]  G. Marsaglia,et al.  A New Class of Random Number Generators , 1991 .

[7]  A convolution algorithm for brachytherapy dose computations in heterogeneous geometries. , 1991, Medical physics.

[8]  R. Nath,et al.  Dose distributions produced by shielded applicators using 241Am for intracavitary irradiation of tumors in the vagina. , 1992, Medical physics.

[9]  R. Nath,et al.  Tissue inhomogeneity correction for brachytherapy sources in a heterogeneous phantom with cylindrical symmetry. , 1992, Medical physics.

[10]  W. Lutz,et al.  Comparison of calculated and measured heterogeneity correction factors for 125I, 137Cs, and 192Ir brachytherapy sources near localized heterogeneities. , 1993, Medical physics.

[11]  P. Hoban Accounting for the variation in collision kerma-to-terma ratio in polyenergetic photon beam convolution. , 1995, Medical physics.

[12]  L. Anderson,et al.  Dosimetry of interstitial brachytherapy sources: Recommendations of the AAPM Radiation Therapy Committee Task Group No. 43 , 1995 .

[13]  J. Williamson,et al.  Experimental validation of Monte Carlo dose calculations about a high-intensity Ir-192 source for pulsed dose-rate brachytherapy. , 1995, Medical physics.

[14]  J F Williamson,et al.  Monte Carlo aided dosimetry of the microselectron pulsed and high dose-rate 192Ir sources. , 1995, Medical physics.

[15]  M Bamberg,et al.  Accuracy of field alignment in radiotherapy of head and neck cancer utilizing individualized face mask immobilization: a retrospective analysis of clinical practice. , 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  R. Sloboda,et al.  EGS4 dosimetry calculations for cylindrically symmetric brachytherapy sources. , 1996, Medical physics.

[17]  K R Russell,et al.  Dose calculation in brachytherapy for a source using a primary and scatter dose separation technique , 1996, Physics in medicine and biology.

[18]  Y. Zhu,et al.  Validation of Monte Carlo dose calculations near 125I sources in the presence of bounded heterogeneities. , 1997, International journal of radiation oncology, biology, physics.

[19]  J F Williamson,et al.  Code of practice for brachytherapy physics: report of the AAPM Radiation Therapy Committee Task Group No. 56. American Association of Physicists in Medicine. , 1997, Medical physics.

[20]  J. Williamson,et al.  Two-dimensional scatter integration method for brachytherapy dose calculations in 3D geometry. , 1997, Physics in medicine and biology.

[21]  J. Williamson,et al.  Monte Carlo-aided dosimetry of a new high dose-rate brachytherapy source. , 1998, Medical physics.

[22]  B. Clark,et al.  Experimental determination of dosimetry functions of Ir-192 sources. , 1998, Medical physics.

[23]  L. Sakelliou,et al.  Monte Carlo and TLD dosimetry of an 192Ir high dose-rate brachytherapy source. , 1998, Medical physics.

[24]  G. Luxton,et al.  Radial dose distribution, dose to water and dose rate constant for monoenergetic photon point sources from 10 keV to 2 MeV:EGS4 Monte Carlo model calculation. , 1999, Medical physics.

[25]  R Nath,et al.  Intravascular brachytherapy physics: report of the AAPM Radiation Therapy Committee Task Group no. 60. American Association of Physicists in Medicine. , 1999, Medical physics.

[26]  A Ahnesjö,et al.  The collapsed cone superposition algorithm applied to scatter dose calculations in brachytherapy. , 2000, Medical physics.

[27]  G. Daskalov Erratum: “Monte Carlo-aided dosimetry of a new high dose-rate brachytherapy source” [Med. Phys. 25, 2200–2208 (1998)] , 2000 .

[28]  A Ahnesjö,et al.  Point kernels and superposition methods for scatter dose calculations in brachytherapy. , 2000, Physics in medicine and biology.

[29]  R Wang,et al.  A Monte Carlo calculation of dosimetric parameters of 90Sr/90Y and 192Ir SS sources for intravascular brachytherapy. , 2000, Medical physics.

[30]  N. Yue,et al.  Dosimetric characterization of a newly designed encapsulated interstitial brachytherapy source of iodine-125-model LS-1 BrachySeed. , 2001, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[31]  F. Ballester,et al.  Technical note: Monte-Carlo dosimetry of the HDR 12i and Plus 192Ir sources. , 2001, Medical physics.

[32]  Z. Chen,et al.  Dose rate constant and energy spectrum of interstitial brachytherapy sources. , 2001, Medical physics.

[33]  W. Dries,et al.  Determination of the accuracy of implant reconstruction and dose delivery in brachytherapy in The Netherlands and Belgium. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[34]  D Baltas,et al.  Beta versus gamma dosimetry close to Ir-192 brachytherapy sources. , 2001, Medical physics.

[35]  R. Sloboda,et al.  Monte Carlo dose parameters of the BrachySeed model LS-1 125I brachytherapy source. , 2002, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[36]  W. V. Prestwich,et al.  Dosimetric properties of the new 125I BrachySeed model LS-1 source. , 2002, Medical physics.

[37]  D Baltas,et al.  Dosimetry comparison of 192Ir sources. , 2002, Medical physics.

[38]  J. Williamson,et al.  Monte Carlo-aided dosimetry of the theragenics TheraSeed model 200 103Pd interstitial brachytherapy seed. , 2002, Medical physics.

[39]  J. Williamson Dosimetric characteristics of the DRAXIMAGE model LS-1 1-125 interstitial brachytherapy source design: a Monte Carlo investigation. , 2002, Medical physics.

[40]  F. Ballester,et al.  Dosimetric characteristics of the CDC-type miniature cylindrical 137Cs brachytherapy sources. , 2002, Medical physics.

[41]  X. Li,et al.  Dose characterization in the near-source region for two high dose rate brachytherapy sources. , 2002, Medical Physics (Lancaster).

[42]  Anders Ahnesjö,et al.  Accounting for high Z shields in brachytherapy using collapsed cone superposition for scatter dose calculation. , 2003, Medical physics.

[43]  J. Williamson,et al.  Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations. , 2004 .